RAC1 and Arthritis: However, preclinical assessment of Rac1 inhibition has been hampered by a lack of compounds specifically targeting Rac1 and by limited analyses of Rac1 in animal models of arthritis, a consequence of early findings demonstrating that genetic deletion of Rac1 in mice results in early embryonic lethality [26].